|
1.Cossart YE, Field AM, Cant B, Widdows D. Parvovirus-like particles inhuman sera. Lancet. 1975 Jan 11;1(7898):72-3.
2.St Amand J, Astell CR. Identification and characterization of a family of 11-kDa proteins encoded by the human parvovirus B19. Virology. 1993 Jan;192(1):121-31.
3.Luo W, Astell CR. A novel protein encoded by small RNAs of parvovirus B19. Virology. 1993 Aug;195(2):448-55.
4.Doerig C, Hirt B, Antonietti JP, Beard P. Nonstructural protein of parvoviruses B19 and minute virus of mice controls transcription. J Virol. 1990 Jan;64(1):387-96.
5.Sol N, Le Junter J, Vassias I, Freyssinier JM, Thomas A, Prigent AF, Rudkin BB, Fichelson S, Morinet F. Possible interactions between the NS-1 protein and tumor necrosis factor alpha pathways in erythroid cell apoptosis induced by human parvovirus B19. J Virol. 1999 Oct;73(10):8762-70.
6.Wilson GM, Jindal HK, Yeung DE, Chen W, Astell CR. Expression of minute virus of mice major nonstructural protein in insect cells: purification and identification of ATPase and helicase activities. Virology. 1991 Nov;185(1):90-8.
7.Chen AY, Zhang EY, Guan W, Cheng F, Kleiboeker S, Yankee TM, Qiu J. The small 11 kDa nonstructural protein of human parvovirus B19 plays a key role in inducing apoptosis during B19 virus infection of primary erythroid progenitor cells. Blood. 2010 Feb 4;115(5):1070-80.
8.Fan MM, Tamburic L, Shippam-Brett C, Zagrodney DB, Astell CR. The small 11-kDa protein from B19 parvovirus binds growth factor receptor-binding protein 2 in vitro in a Src homology 3 domain/ligand-dependent manner. Virology. 2001 Dec 20;291(2):285-91.
9.Kawase M, Momoeda M, Young NS, Kajigaya S. Most of the VP1 unique region of B19 parvovirus is on the capsid surface. Virology. 1995 Aug 20;211(2):359-66.
10.Saikawa T, Anderson S, Momoeda M, Kajigaya S, Young NS. Neutralizing linear epitopes of B19 parvovirus cluster in the VP1 unique and VP1-VP2 junction regions. J Virol. 1993 Jun;67(6):3004-9.
11.Anderson LJ, Tsou C, Parker RA, Chorba TL, Wulff H, Tattersall P, Mortimer PP. Detection of antibodies and antigens of human parvovirus B19 by enzyme-linked immunosorbent assay. J Clin Microbiol. 1986 Oct;24(4):522-6.
12.Erdman DD, Usher MJ, Tsou C, Caul EO, Gary GW, Kajigaya S, Young NS, Anderson LJ. Human parvovirus B19 specific IgG, IgA, and IgM antibodies and DNA in serum specimens from persons with erythema infectiosum. J Med Virol. 1991 Oct;35(2):110-5.
13.Young NS, Brown KE. Parvovirus B19. N Engl J Med. 2004 Feb 5;350(6):586-97.
14.Kerr JR. Pathogenesis of human parvovirus B19 in rheumatic disease. Ann Rheum Dis. 2000 Sep;59(9):672-83.
15.Peterlana D, Puccetti A, Corrocher R, Lunardi C. Serologic and molecular detection of human Parvovirus B19 infection. Clin Chim Acta. 2006 Oct;372(1-2):14-23.
16.Patou G, Pillay D, Myint S, Pattison J. Characterization of a nested polymerase chain reaction assay for detection of parvovirus B19. J Clin Microbiol. 1993 Mar;31(3):540-6.
17.Servey JT, Reamy BV, Hodge J. Clinical presentations of parvovirus B19 infection. Am Fam Physician. 2007 Feb 1;75(3):373-6.
18.Reid DM, Reid TM, Brown T, Rennie JA, Eastmond CJ. Human parvovirus-associated arthritis: a clinical and laboratory description. Lancet. 1985 Feb 23;1(8426):422-5.
19.Söderlund-Venermo M, Hokynar K, Nieminen J, Rautakorpi H, Hedman K. Persistence of human parvovirus B19 in human tissues. Pathol Biol (Paris). 2002 Jun;50(5):307-16.
20.Dorsch S, Liebisch G, Kaufmann B, von Landenberg P, Hoffmann JH, Drobnik W, Modrow S. The VP1 unique region of parvovirus B19 and its constituent phospholipase A2-like activity. J Virol. 2002 Feb;76(4):2014-8.
21.Zhi N, Mills IP, Lu J, Wong S, Filippone C, Brown KE. Molecular and functional analyses of a human parvovirus B19 infectious clone demonstrates essential roles for NS1, VP1, and the 11-kilodalton protein in virus replication and infectivity. J Virol. 2006 Jun;80(12):5941-50.
22.Filippone C, Zhi N, Wong S, Lu J, Kajigaya S, Gallinella G, Kakkola L, Söderlund-Venermo M, Young NS, Brown KE. VP1u phospholipase activity is critical for infectivity of full-length parvovirus B19 genomic clones. Virology. 2008 May 10;374(2):444-52.
23.Leisi R, Ruprecht N, Kempf C, Ros C. Parvovirus B19 uptake is a highly selective process controlled by VP1u, a novel determinant of viral tropism. J Virol. 2013 Dec;87(24):13161-7.
24.Chiu CC, Shi YF, Yang JJ, Hsiao YC, Tzang BS, Hsu TC. Effects of human Parvovirus B19 and Bocavirus VP1 unique region on tight junction of human airway epithelial A549 cells. PLoS One. 2014 Sep 30;9(9):e107970.
25.Tsai CC, Chiu CC, Hsu JD, Hsu HS, Tzang BS, Hsu TC. Human parvovirus B19 NS1 protein aggravates liver injury in NZB/W F1 mice. PLoS One. 2013;8(3):e59724.
26.Allander T, Jartti T, Gupta S, Niesters HG, Lehtinen P, Osterback R, Vuorinen T, Waris M, Bjerkner A, Tiveljung-Lindell A, van den Hoogen BG, Hyypiä T, Ruuskanen O. Human bocavirus and acute wheezing in children. Clin Infect Dis. 2007 Apr 1;44(7):904-10.
27.Campe H, Hartberger C, Sing A. Role of Human Bocavirus infections in outbreaks of gastroenteritis. J Clin Virol. 2008 Nov;43(3):340-2.
28.Costa C, Terlizzi ME, Solidoro P, Libertucci D, Bergallo M, Cavallo R. Detection of parvovirus B19 in the lower respiratory tract. J Clin Virol. 2009 Oct;46(2):150-3. .
29.Tzang BS, Lin TM, Tsai CC, Hsu JD, Yang LC, Hsu TC. Increased cardiac injury in NZB/W F1 mice received antibody against human parvovirus B19 VP1 unique region protein. Mol Immunol. 2011 Jul;48(12-13):1518-24.
30.Nie X, Zhang G, Xu D, Sun X, Li Z, Li X, Zhang X, He F, Li Y. The VP1-unique region of parvovirus B19 induces myocardial injury in mice. Scand J Infect Dis. 2010;42(2):121-8.
31.Naides SJ, Weiner CP. Antenatal diagnosis and palliative treatment of non-immune hydrops fetalis secondary to fetal parvovirus B19 infection. Prenat Diagn. 1989 Feb;9(2):105-14.
32.Moore L, Chambers HM, Foreman AR, Khong TY. A report of human parvovirus B19 infection in hydrops fetalis. First Australian cases confirmed by serology and immunohistology. Med J Aust. 1993 Sep 6;159(5):344-5.
33.Murry CE, Jerome KR, Reichenbach DD. Fatal parvovirus myocarditis in a 5-year-old girl. Hum Pathol. 2001 Mar;32(3):342-5.
34.Kinney JS, Anderson LJ, Farrar J, Strikas RA, Kumar ML, Kliegman RM, Sever JL, Hurwitz ES, Sikes RK. Risk of adverse outcomes of pregnancy after human parvovirus B19 infection. J Infect Dis. 1988 Apr;157(4):663-7.
35.Kurtzman GJ, Cohen BJ, Field AM, Oseas R, Blaese RM, Young NS. Immune response to B19 parvovirus and an antibody defect in persistent viral infection. J Clin Invest. 1989 Oct;84(4):1114-23.
36.Assanasen C, Quinton RA, Buchanan GR. Acute myocardial infarction in sickle cell anemia. J Pediatr Hematol Oncol. 2003 Dec;25(12):978-81.
37.Munro K, Croxson MC, Thomas S, Wilson NJ. Three cases of myocarditis in childhood associated with human parvovirus (B19 virus). Pediatr Cardiol. 2003 Sep-Oct;24(5):473-5.
38.Pankuweit S, Lamparter S, Schoppet M, Maisch B. Parvovirus B19 genome in endomyocardial biopsy specimen. Circulation. 2004 Apr 13;109(14):e179.
39.Bültmann BD, Klingel K, Sotlar K, Bock CT, Baba HA, Sauter M, Kandolf R. Fatal parvovirus B19-associated myocarditis clinically mimicking ischemic heart disease: an endothelial cell-mediated disease. Hum Pathol. 2003 Jan;34(1):92-5.
40.Krishnamurti L, Lanford L, Munoz R. Life threatening parvovirus B19 and herpes simplex virus associated acute myocardial dysfunction in a child with homozygous sickle cell disease. Pediatr Blood Cancer. 2007 Dec;49(7):1019-21.
41.Allander T, Tammi MT, Eriksson M, Bjerkner A, Tiveljung-Lindell A, Andersson B. Cloning of a human parvovirus by molecular screening of respiratory tract samples. Proc Natl Acad Sci U S A. 2005 Sep 6;102(36):12891-6.
42.Schildgen O, Müller A, Allander T, Mackay IM, Völz S, Kupfer B, Simon A. Human bocavirus: passenger or pathogen in acute respiratory tract infections? Clin Microbiol Rev. 2008 Apr;21(2):291-304.
43.Schildgen O, Qiu J, Söderlund-Venermo M. Genomic features of the human bocaviruses. Future Virol. 2012 Jan 1;7(1):31-39.
44.Völz S, Schildgen O, Klinkenberg D, Ditt V, Müller A, Tillmann RL, Kupfer B, Bode U, Lentze MJ, Simon A. A Prospective study of human bocavirus (HBoV) infection in a pediatric university hospital in germany 2005/2006. J Clin Virol. 2007;40(3):229-35. .
45.Kapoor A, Simmonds P, Slikas E, Li L, Bodhidatta L, Sethabutr O, Triki H, Bahri O, Oderinde BS, Baba MM, Bukbuk DN, Besser J, Bartkus J, Delwart E. Human bocaviruses are highly diverse, dispersed, recombination prone, and prevalent in enteric infections. J Infect Dis. 2010 Jun 1;201(11):1633-43.
46.Campe H, H.C., Sing A., Role of Human Bocavirus infections in outbreaks of gastroenteritis. J Clin Virol. 2008 Nov;43(3):340-2.
47.Han TH, Kim CH, Park SH, Kim EJ, Chung JY, Hwang ES. Detection of human bocavirus-2 in children with acute gastroenteritis in south korea. Arch Virol. 2009;154(12):1923-7.
48.Kapoor A, Slikas E, Simmonds P, Chieochansin T, Naeem A, Shaukat S, Alam MM, Sharif S, Angez M, Zaidi S, Delwart E. A newly identified bocavirus species in human stool. J Infect Dis. 2009 Jan 15;199(2):196-200.
49.Streiter M, Malecki M, Prokop A, Schildgen V, Lüsebrink J, Guggemos A, Wisskirchen M, Weiss M, Cremer R, Brockmann M, Schildgen O. Does human bocavirus infection depend on helper viruses? A challenging case report. Virol J. 2011 Aug 29;8:417. .
50.Falcone V, Ridder GJ, Panning M, Bierbaum S, Neumann-Haefelin D, Huzly D. Human bocavirus DNA in paranasal sinus mucosa. Emerg Infect Dis. 2011 Aug;17(8):1564-5.
51.Tijssen P. Molecular and structural basis of the evolution of parvovirus tropism. Acta Vet Hung. 1999;47(3):379-94.
52.Kantola K, Hedman L, Arthur J, Alibeto A, Delwart E, Jartti T, Ruuskanen O, Hedman K, Söderlund-Venermo M. Seroepidemiology of human bocaviruses 1-4. J Infect Dis. 2011 Nov;204(9):1403-12.
53.Kupfer B, Vehreschild J, Cornely O, Kaiser R, Plum G, Viazov S, Franzen C, Tillmann RL, Simon A, Müller A, Schildgen O. Severe pneumonia and human bocavirus in adult. Emerg Infect Dis. 2006 Oct;12(10):1614-6.
54.Heydari H, Mamishi S, Khotaei GT, Moradi S. Fatal type 7 adenovirus associated with human bocavirus infection in a healthy child. J Med Virol. 2011 Oct;83(10):1762-3.
55.Antunes H, Rodrigues H, Silva N, Ferreira C, Carvalho F, Ramalho H, Gonçalves A, Branca F. Etiology of bronchiolitis in a hospitalized pediatric population: prospective multicenter study. J Clin Virol. 2010 Jun;48(2):134-6.
56.Calvo C, García-García ML, Pozo F, Carvajal O, Pérez-Breña P, Casas I. Clinical characteristics of human bocavirus infections compared with other respiratory viruses in spanish children. Pediatr Infect Dis J. 2008 Aug;27(8):677-80.
57.Deng Y, Gu X, Zhao X, Luo J, Luo Z, Wang L, Fu Z, Yang X, Liu E. High viral load of human bocavirus correlates with duration of wheezing in children with severe lower respiratory tract infection. PLoS One. 2012;7(3):e34353.
58.Franz A, Adams O, Willems R, Bonzel L, Neuhausen N, Schweizer-Krantz S, Ruggeberg JU, Willers R, Henrich B, Schroten H, Tenenbaum T. Correlation of viral load of respiratory pathogens and co-infections with disease severity in children hospitalized for lower respiratory tract infection. J Clin Virol. 2010 Aug;48(4):239-45.
59.Smuts H, Hardie D. Human bocavirus in hospitalized children, South Africa. Emerg Infect Dis. 2006 Sep;12(9):1457-8.
60.Vallet C, Pons-Catalano C, Mandelcwajg A, Wang A, Raymond J, Lebon P, Gendrel D. Human bocavirus: A cause of severe asthma exacerbation in children. J Pediatr. 2009 Aug;155(2):286-8.
61.Müller A, Klinkenberg D, Vehreschild J, Cornely O, Tillmann RL, Franzen C, Simon A, Schildgen O. Low prevalence of human metapneumovirus and human bocavirus in adult immunocompromised high risk patients suspected to suffer from pneumocystis pneumonia. J Infect. 2009 Mar;58(3):227-31.
62.Bohmer, A.S., V.; Lusebrink, J.; Ziegler, S.; Tillmann, R.L.; Kleines, M.; Schildgen, O., Novel application for isothermal nucleic acid sequence-based amplification (NASBA). J. Virol. Methods 2009, 158, 199–201.
63.Söderlund-Venermo M, Lahtinen A, Jartti T, Hedman L, Kemppainen K, Lehtinen P, Allander T, Ruuskanen O, Hedman K. Clinical assessment and improved diagnosis of bocavirus-induced wheezing in children, Finland. Emerg Infect Dis. 2009 Sep;15(9):1423-30.
64.Don M, Söderlund-Venermo M, Hedman K, Ruuskanen O, Allander T, Korppi M. Don''t forget serum in the diagnosis of human bocavirus infection. J Infect Dis. 2011 Apr 1;203(7):1031-2.
65.Don M, Söderlund-Venermo M, Valent F, Lahtinen A, Hedman L, Canciani M, Hedman K, Korppi M. Serologically verified human bocavirus pneumonia in children. Pediatr Pulmonol. 2010 Feb;45(2):120-6.
66.Hedman L, Söderlund-Venermo M, Jartti T, Ruuskanen O, Hedman K. Dating of human bocavirus infection with protein-denaturing IgG-avidity assays-Secondary immune activations are ubiquitous in immunocompetent adults. J Clin Virol. 2010 May;48(1):44-8.
67.Kantola K, Hedman L, Allander T, Jartti T, Lehtinen P, Ruuskanen O, Hedman K, Söderlund-Venermo M. Serodiagnosis of human bocavirus infection. Clin Infect Dis. 2008 Feb 15;46(4):540-6.
68.Korppi M, Jartti T, Hedman K, Söderlund-Venermo M. Serologic diagnosis of human bocavirus infection in children. Pediatr Infect Dis J. 2010 Apr;29(4):387.
69.Jartti T, Söderlund-Venermo M, Allander T, Vuorinen T, Hedman K, Ruuskanen O. No efficacy of prednisolone in acute wheezing associated with human bocavirus infection. Pediatr Infect Dis J. 2011 Jun;30(6):521-3.
70.Chow BD, Esper FP. The human bocaviruses: a review and discussion of their role in infection. Clin Lab Med. 2009 Dec;29(4):695-713.
71.Chen AY, Cheng F, Lou S, Luo Y, Liu Z, Delwart E, Pintel D, Qiu J. Characterization of the gene expression profile of human bocavirus. Virology. 2010 Aug 1;403(2):145-54.
72.Qu XW, Liu WP, Qi ZY, Duan ZJ, Zheng LS, Kuang ZZ, Zhang WJ, Hou YD. Phospholipase A2-like activity of human bocavirus VP1 unique region. Biochem Biophys Res Commun. 2008 Jan 4;365(1):158-63.
73.Böhmer A, Schildgen V, Lüsebrink J, Ziegler S, Tillmann RL, Kleines M, Schildgen O. Novel application for isothermal nucleic acid sequence-based amplification (NASBA). J Virol Methods. 2009 Jun;158(1-2):199-201.
74.Dijkman R, Koekkoek SM, Molenkamp R, Schildgen O, van der Hoek L. Human bocavirus can be cultured in differentiated human airway epithelial cells. J Virol. 2009 Aug;83(15):7739-48.
75.Huang Q, Deng X, Yan Z, Cheng F, Luo Y, Shen W, Lei-Butters DC, Chen AY, Li Y, Tang L, Söderlund-Venermo M, Engelhardt JF, Qiu J. Establishment of a reverse genetics system for studying human bocavirus in human airway epithelia. PLoS Pathog. 2012;8(8):e1002899.
76.Deng X, Yan Z, Luo Y, Xu J, Cheng F, Li Y, Engelhardt JF, Qiu J. In vitro modeling of human bocavirus 1 infection of polarized primary human airway epithelia. J Virol. 2013 Apr;87(7):4097-102.
77.Mannheim D, Herrmann J, Versari D, Gössl M, Meyer FB, McConnell JP, Lerman LO, Lerman A. Enhanced expression of Lp-PLA2 and lysophosphatidylcholine in symptomatic carotid atherosclerotic plaques. Stroke. 2008 May;39(5):1448-55.
78.Gong HP, Du YM, Zhong LN, Dong ZQ, Wang X, Mao YJ, Lu QH. Plasma lipoprotein-associated phospholipase A2 in patients with metabolic syndrome and carotid atherosclerosis. Lipids Health Dis. 2011 Jan 19;10:13.
79.Berry E, Hernandez-Anzaldo S, Ghomashchi F, Lehner R, Murakami M, Gelb M2, Kassiri Z, Wang X, Fernandez-Patron C. Matrix metalloproteinase-2 negatively regulates cardiac secreted phospholipase A2 to modulate inflammation and fever. J Am Heart Assoc. 2015 Mar 27;4(4).
80.Shuvalova YA, Khasanova ZB, Kaminnaya VI, Samoilova EV, Korotaeva AA, Rubanovich AV, Kaminnyi AI. The association of PLA2G2A single nucleotide polymorphisms with type IIa secretory phospholipase A2 level but not its activity in patients with stable coronary heart disease. Gene. 2015 Jun 10;564(1):29-34.
81.Guardiola M, Exeter HJ, Perret C, Folkersen L, Van''t Hooft F, Eriksson P, Franco-Cereceda A, Paulsson-Berne G, Palmen J2, Li K, Cooper JA, Khaw KT, Mallat Z, Ninio E, Karabina SA, Humphries SE, Boekholdt SM, Holmes MV, Talmud PJ. PLA2G10 Gene Variants, sPLA2 Activity, and Coronary Heart Disease Risk. Circ Cardiovasc Genet. 2015 Apr;8(2):356-62.
82.Schulz R. TNFα in myocardial ischemia/reperfusion: damage vs. protection. J Mol Cell Cardiol. 2008 Dec;45(6):712-4.
83.Schulz R, Heusch G. Tumor Necrosis Factor-alpha and Its Receptors 1 and 2 Yin and Yang in Myocardial Infarction? Circulation. 2009 Mar 17;119(10):1355-7.
84.Galea J, Armstrong J, Gadsdon P, Holden H, Francis SE, Holt CM. Interleukin-1 beta in coronary arteries of patients with ischemic heart disease. Arterioscler Thromb Vasc Biol. 1996 Aug;16(8):1000-6.
85.Yang S, Zheng R, Hu S, Ma Y, Choudhry MA, Messina JL, Rue LW III., Bland KI, Chaudry IH. Mechanism of cardiac depression after trauma-hemorrhage: increased cardiomyocyte IL-6 and effect of sex steroids on IL-6 regulation and cardiac function. Am J Physiol Heart Circ Physiol. 2004 Nov;287(5):H2183-91.
86.Zandi E, Karin M. Bridging the Gap: Composition, Regulation, and Physiological Function of the IκB Kinase Complex. Mol Cell Biol. 1999 Jul;19(7):4547-51.
87.Kaufman CK, Fuchs E. It''s Got You Covered: NF-κB in the Epidermis. J Cell Biol. 2000 May 29;149(5):999-1004.
88.Baldwin AS Jr. Series introduction: the transcription factor NF-kappaB and human disease. J Clin Invest. 2001;107:3-6.
89.Shimizu N, Yoshiyama M, Omura T, Hanatani A, Kim S, Takeuchi K, Iwao H, Yoshikawa J. Activation of mitogen-activated protein kinases and activator protein-1 in myocardial infarction in rats. Cardiovasc Res. 1998 Apr;38(1):116-24.
90.Wang Y, Huang S, Sah VP, Ross J Jr, Brown JH, Han J, Chien KR. Cardiac muscle cell hypertrophy and apoptosis induced by distinct members of the p38 mitogen-activated protein kinase family. J Biol Chem. 1998 Jan 23;273(4):2161-8.
91.Gardner DG. Natriuretic peptides: markers or modulators of cardiac hypertrophy? Trends Endocrinol Metab. 2003;14(9):411-6.
92.Braunersreuther V, Mach F, Steffens S. The specific role of chemokines in atherosclerosis. Thromb Haemost. 2007 May;97(5):714-21.
93.Dufour JH, Dziejman M, Liu MT, Leung JH, Lane TE, Luster AD. IFN-gamma-inducible protein 10 (IP-10; CXCL10)-deficient mice reveal a role for IP-10 in effector T cell generation and trafficking. J Immunol. 2002 Apr 1;168(7):3195-204.
94.Rothenbacher D, Müller-Scholze S, Herder C, Koenig W, Kolb H. Differential expression of chemokines, risk of stable coronary heart disease, and correlation with established cardiovascular risk markers. Arterioscler Thromb Vasc Biol. 2006 Jan;26(1):194-9.
95.Nigro G, Bastianon V, Colloridi V, Ventriglia F, Gallo P, D''Amati G, Koch WC, Adler SP. Human parvovirus B19 infection in infancy associated with acute and chronic lymphocytic myocarditis and high cytokine levels: report of 3 cases and review. Clin Infect Dis. 2000 Jul;31(1):65-9.
96.Kerr JR, Tyrrell DA. Cytokines in parvovirus B19 infection as an aid to understanding chronic fatigue syndrome. Curr Pain Headache Rep. 2003 Oct;7(5):333-41.
97.Blaszczyk J, Coillie EV, Proost P, Damme JV, Opdenakker G, Bujacz GD, Wang JM, Ji X. Complete crystal structure of monocyte chemotactic protein-2, a CC chemokine that interacts with multiple receptors. Biochemistry. 2000 Nov 21;39(46):14075-81.
98.Strnisková M, Ravingerová T, Neckár J, Kolár F, Pastoreková S, Barancík M. Changes in the expression and/or activation of regulatory proteins in rat hearts adapted to chronic hypoxia. Gen Physiol Biophys. 2006 Mar;25(1):25-41.
99.Arakawa N, Nakamura M, Endo H, Sugawara S, Suzuki T, Hiramori K. Brain natriuretic peptide and cardiac rupture after acute myocardial infarction. Intern Med. 2001 Mar;40(3):232-6.
100.DG., G., Natriuretic peptides: markers or modulators of cardiac hypertrophy? Trends Endocrinol Metab. 2003;14(9):411-6.
101.Chen DY, Chen YM, Tzang BS, Lan JL, Hsu TC. Th17-related cytokines in systemic lupus erythematosus patients with dilated cardiomyopathies: a possible linkage to parvovirus B19 infection. PLoS One. 2014 Dec 2;9(12):e113889.
102.Schultheiss HP, Kühl U, Cooper LT. The management of myocarditis. Eur Heart J. 2011 Nov;32(21):2616-25.
|